Anticholinergic therapy: Do the patients take the pills prescribed?

Archives of Gynecology and Obstetrics

Volumn 284, Issue 3, 2011, Pages 663-666

  Jundt, Katharina ^a   Schreyer, Kathrin ^a   Friese, Klaus ^a   Peschers, Ursula ^b  

^a UNIVERSITY OF MUNICH   (Germany)

^b Chirurgische Klinik Munchen Bogenhausen   (Germany)

Author keywords

Anticholinergic therapy; Drug therapy; Incontinence; Overactive bladder

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT; OXYBUTYNIN; PROPIVERINE; SOLIFENACIN; TOLTERODINE; TROSPIUM CHLORIDE; MUSCARINIC RECEPTOR BLOCKING AGENT;

ADULT; AGED; ARTICLE; ATTITUDE TO ILLNESS; CONTROLLED STUDY; DRUG PREFERENCE; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GENERAL CONDITION IMPROVEMENT; HUMAN; MAJOR CLINICAL STUDY; MIXED INCONTINENCE; NOCTURIA; OVERACTIVE BLADDER; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT COUNSELING; PATIENT PREFERENCE; PHYSICAL EXAMINATION; PRESCRIPTION; THERAPY EFFECT; TREATMENT WITHDRAWAL; UNSPECIFIED SIDE EFFECT; URINARY FREQUENCY; URINARY URGENCY; INTERVIEW; MIDDLE AGED; STATISTICS; TREATMENT FAILURE;

ADULT; AGED; AGED, 80 AND OVER; CHOLINERGIC ANTAGONISTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERVIEWS AS TOPIC; MEDICATION ADHERENCE; MIDDLE AGED; MUSCARINIC ANTAGONISTS; PARASYMPATHOLYTICS; TREATMENT FAILURE; URINARY BLADDER, OVERACTIVE; YOUNG ADULT;

EID: 84856001063     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-010-1720-x     Document Type: Article

References (15)

1. Abrams P, Cardozo L, Fall M, Griffiths DJ et al (2002) The standardisation of terminology of lower urinary tract function. Neurourol Urodynam 21:167-178
2. Stewart WF, Van Rooyen JB, Cundiff GW, Abrams P et al (2003) Prevalence and burden of overactive bladder in the United States. World J Urol 20:327-336 (Pubitemid 44175300)
3. Roxburgh C, Cook J, Dublin N (2007) Anticholinergic drugs versus other medications for overactive bladder syndrome in adults. Cochrane Database Syst Rev CD003190
4. Abrams P, Freeman RM, Anderstrom C, Mattiasson A (1998) Tolterodine, a new antimuscarinic agent; as effective but better tolerated than oxybutinin in patients with an overactive bladder. Br J Urol 81:801-810 (Pubitemid 28300606)
5. Zinner NR, Tuttle J, Marks L (2005) Tolterodine, a new antimuscarinic agent: as effective but better tolerated than oxybutinin in patients with an overactive bladder. World J Urol 23:248-252
6. Kelleher CJ, Cardozo L, Khullar V, Salvatore S (1997) A medium-term analysis of the subjective efficacy of treatment for women with detrusor instability and low bladder compliance. Br J Obstet Gynaecol 104:988-993 (Pubitemid 27400176)
7. Shaya FT, Blume S, Gu A, Zyczynski T, Jumadilova Z (2005) Persistence with overactive bladder pharmacotherapy in a Medicaid population. Am J Manag Care 11:S121-S129 (Pubitemid 41022720)
8. Yu YF, Nichol MB, Yu AP, Ahn J (2005) Persistence and adherence of medications for chronic overactive bladder/urinary incontinence in the california medicaid program. Value Health 8:495-505 (Pubitemid 41726103)
9. Gopal M, Haynes K, Bellamy SL, Arya LA (2008) Discontinuation rates of anticholinergic medications used for the treatment of lower urinary tract symptoms. Obstet Gynecol 112(6):1311-1318
10. Campbell UB, Stang P, Barron R (2008) Survey assessment of continuation of and satisfaction with pharmacological treatment for urinary incontinence. Value Health 11:726-732 (Pubitemid 352032811)
11. Burgio KL (2004) Behavioral treatment options for urinary incontinence. Gastroenterology 126:S82-S89 (Pubitemid 38036847)
12. Ward KL, Hilton P, Browning J (2000) (on behalf of the UK and Ireland TVT Trial Group). A randomized trial of colposuspension and tension-free vaginal tape (TVT) for primary genuine stress incontinence. Neurourol Urodynam 20:386-389
13. Reeves P, Irwin D, Kelleher C, Milsom I et al (2006) The current and future burden and cost of overactive bladder in five European countries. Eur Urol 50:1050-1057 (Pubitemid 44486484)
14. Zellner M, Madersbacher H, Palmtag H, Stöhrer M, Bödeker RH, P195 Study Group (2009) Trospium chloride and oxybutynin hydrochloride in a german study of adults with urinary urge incontinence: results of a 12-week, multicenter, randomized, double-blind, parallel-group, flexible-dose noninferiority trial. Clin Ther 31(11):2519-2539
15. Staskin D, Kay G, Tannenbaum C, Goldman HB, Bhashi K, Ling J, Oefelein MG (2010) Trospium chloride has no effect on memory testing and is assay undetectable in the central nervous system of older patients with overactive bladder. Int J Clin Pract 64(9):1294-1300 (Epub 2010 Jun. 17)